Thu, November 2, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Alethia Young Maintained (AGIO) at Buy with Increased Target to $66 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Lynne Collier Maintained (CAKE) at Hold with Decreased Target to $48 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
John Glass Maintained (CAKE) at Hold with Decreased Target to $44 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Jeffrey Bernstein Maintained (CAKE) at Hold with Decreased Target to $43 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Mark Kalinowski Maintained (CAKE) at Hold with Decreased Target to $40 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
A.J. Rice Initiated (ACHC) at Hold and Held Target at $35 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Craig Schmidt Downgraded (AAT) to Hold on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Craig Siegenthaler Maintained (APO) at Hold with Increased Target to $35 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
William Katz Maintained (APO) at Strong Buy with Increased Target to $38 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Ole Slorer Maintained (ASC) at Hold with Increased Target to $9 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Matthew O"Brien Downgraded (ZBH) to Hold on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
David Lewis Maintained (ZBH) at Buy with Decreased Target to $136 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Joanne Wuensch Maintained (ZBH) at Buy with Decreased Target to $135 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Timothy Thein Maintained (ALSN) at Strong Buy with Increased Target to $50 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Rahul Jasuja Maintained (ALNY) at Strong Buy with Increased Target to $240 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Ryan Tunis Maintained (ALL) at Hold with Increased Target to $95 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Bill Sutherland Upgraded (AMED) to Strong Buy on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Sheryl Skolnick Upgraded (AMED) to Strong Buy on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Anjaneya Singh Maintained (BFAM) at Hold with Increased Target to $90 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Jeffrey Silber Maintained (BFAM) at Hold with Increased Target to $90 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Mark Jarvi Downgraded (BEP) to Hold on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Alvin Concepcion Maintained (WBA) at Strong Buy with Decreased Target to $81 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Tom Abrams Maintained (WES) at Hold with Decreased Target to $52 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Christopher Tillett Maintained (WES) at Buy with Decreased Target to $62 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Danyal Hussain Maintained (WEX) at Hold with Increased Target to $123 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Darrin Peller Maintained (WEX) at Hold with Increased Target to $129 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Glenn Greene Maintained (WEX) at Buy with Increased Target to $130 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Jason Mills Maintained (ATRC) at Strong Buy with Decreased Target to $24 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Richard Newitter Maintained (AXGN) at Buy with Increased Target to $26 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Anjaneya Singh Maintained (VRSK) at Hold with Increased Target to $92 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Manav Patnaik Maintained (VRSK) at Buy with Increased Target to $105 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Toni Kaplan Maintained (VRSK) at Hold with Increased Target to $90 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Jeffrey Silber Maintained (VRSK) at Hold with Increased Target to $91 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Robert Peters Maintained (TRI) at Hold with Decreased Target to $53 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Toni Kaplan Maintained (TRI) at Hold with Decreased Target to $51 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Gena Wang Maintained (BLUE) at Buy with Increased Target to $162 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Dane Leone Upgraded (BLUE) to Strong Buy on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Matthew Mishan Maintained (STE) at Buy with Increased Target to $101 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Scott Devitt Downgraded (SQ) to Hold on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Douglas Harned Maintained (SPR) at Buy with Increased Target to $98 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Robert Spingarn Maintained (SPR) at Buy with Increased Target to $97 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Farha Aslam Downgraded (THS) to Hold on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Scott Fidel Initiated (THC) at Hold and Held Target at $15 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Bill Dreher Initiated (TPR) at Buy and Held Target at $50 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Kenneth Zener Upgraded (TOL) to Buy on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
A.J. Rice Initiated (UHS) at Buy and Held Target at $126 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Scott Fidel Initiated (UNH) at Buy and Held Target at $233 on, Nov 2nd, 2017
[ Thu, Nov 02nd 2017 ]: WOPRAI
Paul Bieber Maintained (YELP) at Buy with Increased Target to $51 on, Nov 2nd, 2017

Gena Wang Maintained (BLUE) at Buy with Increased Target to $162 on, Nov 2nd, 2017

Gena Wang of Barclays, Maintained "bluebird bio, Inc." (BLUE) at Buy with Increased Target from $151 to $162 on, Nov 2nd, 2017.

Gena has made no other calls on BLUE in the last 4 months.



There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 2 agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Biren Amin of "Jefferies" Downgraded from Strong Buy to Hold on, Wednesday, October 11th, 2017
  • Vincent Chen of "Bernstein" Initiated at Hold and Held Target at $109 on, Thursday, July 27th, 2017


These are the ratings of the 3 analyists that currently disagree with Gena

  • Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $162 on, Monday, October 30th, 2017
  • Josh Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy on, Monday, October 16th, 2017
  • Matthew Harrison of "Morgan Stanley" Downgraded from Hold to Sell on, Monday, October 2nd, 2017